Current landscape of US Food and Drug Administration use of expedited regulatory approvals for colorectal cancer care
{{output}}
Background: US Food and Drug Administration (FDA) expedited regulatory pathways (ERPs) accelerate the availability of drugs and diagnostic tests for severe conditions and fill unmet medical needs. ERPs accelerate access to new th... ...
